Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatment

Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatment

Introduction: Intra-arterial hepatic (IAH) treatment has shown promising results in the management of patients with unresectable colorectal liver metastases (CRLM) the prognosis of which is poor. Bevacizumab adjunction to standard chemotherapy has been shown to improve survival of this patient popul...

Full description

Bibliographic Details
Main Authors: Eugénie Rigault, Benjamin Lacas, Olivier Glehen, Denis Smith, Eric Dupont-Bierre, Rosine Guimbaud, David Malka, Valérie Boige, Alina Fuerea, Jean-Pierre Pignon, Michel Ducreux
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Intra-arterial hepatic
Bevacizumab
Systemic chemotherapy
Liver metastasis
Colorectal cancer
Phase 2 trial
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222001654

Similar Items

Similar Items